Search

everythinglearnresearchcommunity

for

Search:↓

A rare ovarian cancer with a good outlook was found in a woman with unusual hair growth and abdominal symptoms.

Laparoscopic ovarian drilling improves menstrual cycles, hormone levels, and pregnancy rates in women with PCOS.

Treating prolactinoma doesn't significantly affect hirsutism or cause high androgen levels.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Women with more body hair tend to have thicker belly fat and more metabolic health issues.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Pregnancy and parenthood do not significantly change PCOS symptoms, but childless women have less hirsutism and weight gain.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

Testosterone affects skin by increasing oil production and influences hair growth.

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

Oral contraceptives can help manage acne by reducing androgen levels.

The oral testosterone effectively increased testosterone levels and reduced SHBG, showing promise for treating testosterone deficiency.

Isotretinoin treatment in teens with acne can cause hormonal changes, leading to menstrual irregularity and increased hirsutism.

Norplant implants lower some androgen levels but don't significantly change sexual function.

Metformin can start ovulation and may lower 17P response in PCOS, but six months is too short to improve hair growth or change body fat distribution.

Birth control pills help treat acne, especially when caused by excess male hormones, and are safe to use with antibiotics.

Genetic response to androgens is key in female pattern baldness, not SHBG levels.

Female pattern hair loss severity is linked to physical signs of high androgens, not blood hormone levels.

The HSD3B1 variant increases hair loss risk in overweight women with PCOS.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Androgenetic alopecia in males is linked to hormone levels and the enzyme 5-alpha reductase.

People with hair loss have different hormone levels, and these hormones can affect hair growth.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Women with androgenetic alopecia have lower SHBG levels.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Melatonin may improve some hormonal and inflammatory issues in women with PCOS.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.